This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

But the evidence looks only at its effect on overweight or obese people, so we don’t yet know its total impact.Wheate points ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

GLP-1s seem to be everywhere. The appetite suppressant drugs, with brand names like Ozempic and Wegovy, have grown in ...

GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...